Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low. If you miss an appointment for a scheduled dose of this medicine, contact your doctor immediately for further instructions.
Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Clozapine (severe)
Diltiazem (moderate)
Warfarin (moderate)
Live attenuated vaccines and related products (severe)
This medicine is used for the treatment of different types of malignant cancers such as multiple myeloma (cancer that affects plasma cells), certain types of leukemia (blood cancer), including chronic lymphocytic leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, and acute myelogenous leukemia, Hodgkin's lymphoma and non-Hodgkin's lymphoma (types of cancer that affects certain cells called lymphocytes of the lymphatic system), ovarian cancer (cancer that affects the female reproductive system), breast cancer, retinoblastoma (eye cancer), etc.
Black or tarry stools
Pain at the injection site
Hair loss
Fever and chills
Weakness
Loss of appetite
Nausea and Vomiting
Diarrhea
Headache
Increased sweating
Skin rash
This medicine is not recommended for use in patients with a known allergy to ZYCRAM 200mg Injection Vial , other alkylating agents, or any other inactive ingredients present along with the formulation.
This medicine is not recommended for use in patients with urinary flow obstruction or cystitis (inflammation of the urinary bladder) due to the increased risk of worsening of the patient's condition.
This medicine is not recommended in patients with severe bone marrow suppression (decrease in the production of blood cells).